RxDoctor Payments Data

Laura Contreras

Family · North Kansas City, MONPI 1053831370

Payments from drug & device makers

$3,403in general payments, 2019–2025

Across 147 payments — averaging $23.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Novartis$432
  • Amgen$392
  • Johnson & Johnson$246
  • Merck$177
  • Boehringer Ingelheim$118
  • plus $580 from 13 others

What the payments were for

  • Travel & lodging$1,08532%
  • Food & beverage$2,31868%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,403 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$34,261
Medicare patients
256
Services billed
427

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban266$262,674
XareltoRivaroxaban140$116,744
EntrestoSacubitril/Valsartan63$62,626
Repatha SureclickEvolocumab37$50,790
BrilintaTicagrelor25$15,434
JardianceEmpagliflozin23$12,722
Prasugrel Hcl58$4,047
Flecainide Acetate88$3,562
Colesevelam Hcl11$2,577
Atorvastatin Calcium238$2,540
Ranolazine ErRanolazine24$2,355
Carvedilol227$2,186
Metoprolol Succinate191$1,899
Diltiazem 24hr Er (Cd)Diltiazem Hcl71$1,339
Valsartan25$1,235

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$47$262,674266 claims
Johnson & JohnsonXarelto$246$116,744140 claims
NovartisEntresto$432$62,62663 claims
AstraZenecaBrilinta$112$15,43425 claims
Boehringer IngelheimJardiance$118$12,72223 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,812 family providers in Missouri.

Other family in North Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →